Mylan receives approval for Parkinson’s disease treatment

Alaric DeArment

9/30/2009

PITTSBURGH The Food and Drug Administration has approved a generic version of a drug for Parkinson’s disease.

Mylan announced the approval Wednesday, for its carbidopa and levodopa tablets in the 10 mg/100 mg, 25 mg/100 mg and 25 mg/250 mg strengths.

The tablets are a generic version of Bristol-Myers Squibb’s Sinemet. Branded and generic versions of the drug had sales of $79 million for the 12 months ending June 30, according to IMS Health data.

CVS Weight Management program improves health outcomes, lowers costs

As of Feb. 1, the CVS Weight Management program is available to more than 3.5 million CVS Caremark plan members.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Kiss Products unveils ‘Wicked’-inspired nail, lash collection

The collection includes lashes and nails from Kiss Nails, imPress Nails, Falscara and imPress Faslsies lines.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.